Breaking News Instant updates and real-time market news.

2022-07-07 09:04:16 AREB American Rebel / + 09:04 07/07/22 07/07 09:04 07/07/22 09:04	American Rebel to acquire Champion Safe Company in $9.9M transaction American Rebel Holdings announced it has entered into an agreement to acquire Utah-based Champion Safe Company, and its ancillary companies. Champion is a manufacturer of gun safes with an industry wide reputation for security, fire protection, quality of finish and workmanship. The transaction is valued at approximately $9.9 million and is expected to add more than $20 million in revenues to American Rebel and be accretive to net income.

2022-07-07 09:04:16

AREB

American Rebel

/ +

09:04

07/07/22

07/07

09:04

07/07/22

09:04

American Rebel to acquire Champion Safe Company in $9.9M transaction

American Rebel Holdings announced it has entered into an agreement to acquire Utah-based Champion Safe Company, and its ancillary companies. Champion is a manufacturer of gun safes with an industry wide reputation for security, fire protection, quality of finish and workmanship. The transaction is valued at approximately $9.9 million and is expected to add more than $20 million in revenues to American Rebel and be accretive to net income.

OTHER BREAKING NEWS FROM THE FLY

Downgrade	e.l.f. Beauty downgraded to Market Perform at Cowen on valuation » 05:57 08/12/22 08/12 05:57 08/12/22 05:57 ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 07/05/22 Chairman of e.l.f. Beauty Tarang Amin sells $1.3M in company shares 06/07/22 e.l.f. Beauty CEO: We continue to take market share ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 05:38 Today Cowen e.l.f. Beauty downgraded to Market Perform from Outperform at Cowen 08/04/22 Truist e.l.f. Beauty price target raised to $40 from $35 at Truist 07/21/22 JPMorgan e.l.f. Beauty price target raised to $35 from $30 at JPMorgan 05/26/22 Raymond James e.l.f. Beauty price target lowered to $27 from $33 at Raymond James ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 08/03/22 e.l.f. Beauty raises FY23 EPSE view to 84c-87c from 78c-81c 08/03/22 e.l.f. Beauty reports Q1 EPS 39c, consensus 23c 05/25/22 e.l.f. Beauty sees FY23 adjusted EPS 78c-81c, consensus 84c 05/25/22 e.l.f. Beauty reports Q4 adjusted EPS 13c, consensus 6c ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 07/11/22 Fly Insider: Karuna Therapeutics, HP among weeks notable insider trades 05/25/22 Fly Intel: After-Hours Movers 04/06/22 What You Missed On Wall Street On Wednesday 04/06/22 What You Missed On Wall Street This Morning 11/02/22 e.l.f. Beauty - ELF 08/25/22 E.L.F. BEAUTY 09/13/22 e.l.f. Beauty 09/14/22 e.l.f. Beauty
Upgrade	Alliant Energy upgraded to Buy from Neutral at BofA » 05:56 08/12/22 08/12 05:56 08/12/22 05:56 LNT Alliant Energy $61.67 / -0.295 (-0.48%) BofA analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LNT Alliant Energy $61.67 / -0.295 (-0.48%) 07/26/22 Mercury Marine, Alliant Energy partner to build solar array 06/23/22 Alliant Energy adjusts timing of Wisconsin-based generation retirement dates 04/05/22 Alliant Energy names two new executive officers LNT Alliant Energy $61.67 / -0.295 (-0.48%) 08/08/22 BofA Alliant Energy price target raised to $62 from $57 at BofA 07/18/22 Barclays Alliant Energy price target lowered to $62 from $68 at Barclays 05/31/22 Argus Alliant Energy price target raised to $70 from $68 at Argus 05/17/22 BofA Alliant Energy upgraded to Neutral from Underperform at BofA LNT Alliant Energy $61.67 / -0.295 (-0.48%) 04/28/22 Alliant Energy still sees 2022 EPS $2.67-$2.81, consensus $2.75 04/28/22 Alliant Energy reports Q1 EPS 77c , consensus 72c 02/17/22 Alliant Energy reports Q4 EPS 35c, consensus 36c
Downgrade	Sally Beauty downgraded to Market Perform from Outperform at Cowen » 05:56 08/12/22 08/12 05:56 08/12/22 05:56 SBH Sally Beauty $15.20 / +0.66 (+4.54%) Cowen analyst Oliver Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SBH Sally Beauty $15.20 / +0.66 (+4.54%) 06/16/22 Sally Beauty falls -12.7% SBH Sally Beauty $15.20 / +0.66 (+4.54%) 06/29/22 Raymond James Raymond James cuts Sally Beauty to Underperform on exposure low-income consumer 06/29/22 Raymond James Sally Beauty downgraded to Underperform from Market Perform at Raymond James 06/16/22 Morgan Stanley Sally Beauty downgraded to Underweight from Equal Weight at Morgan Stanley 05/06/22 Cowen Sally Beauty price target lowered to $20 from $30 at Cowen SBH Sally Beauty $15.20 / +0.66 (+4.54%) 08/04/22 Sally Beauty lowers FY22 revenue growth view to down 2% from 0%-down 2% 08/04/22 Sally Beauty reports Q3 adjusted EPS 55c, consensus 59c 05/05/22 Sally Beauty lowers FY22 revenue growth view to 0%-down 2% from up 3%-4% 05/05/22 Sally Beauty reports Q2 adjusted EPS 47c, consensus 51c SBH Sally Beauty $15.20 / +0.66 (+4.54%) 06/29/22 What You Missed On Wall Street On Wednesday 06/29/22 What You Missed On Wall Street This Morning 06/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/16/22 What You Missed On Wall Street On Thursday
Upgrade	Fresenius SE upgraded to Buy from Hold at HSBC » 05:54 08/12/22 08/12 05:54 08/12/22 05:54 FSNUY Fresenius SE $6.38 / -0.01 (-0.16%) HSBC analyst Sezgi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research FSNUY Fresenius SE $6.38 / -0.01 (-0.16%) 08/08/22 Credit Suisse Fresenius SE price target lowered to EUR 30 from EUR 38 at Credit Suisse 08/05/22 Deutsche Bank Fresenius SE price target lowered to EUR 28 from EUR 36 at Deutsche Bank 08/05/22 Barclays Fresenius SE price target lowered to EUR 35 from EUR 52.50 at Barclays 07/29/22 DZ Bank Fresenius SE downgraded to Hold from Buy at DZ Bank
Upgrade	UPM-Kymmene upgraded to Buy from Hold at Jefferies » 05:53 08/12/22 08/12 05:53 08/12/22 05:53 UPMMY UPM-Kymmene $34.60 / +0.39 (+1.14%) Jefferies analyst Cole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research UPMMY UPM-Kymmene $34.60 / +0.39 (+1.14%) 07/22/22 Morgan Stanley UPM-Kymmene price target lowered to EUR 40 from EUR 41 at Morgan Stanley 07/19/22 Credit Suisse UPM-Kymmene price target lowered to EUR 33.80 from EUR 36.80 at Credit Suisse 06/14/22 Danske Bank UPM-Kymmene downgraded to Hold from Buy at Danske Bank 04/25/22 Credit Suisse UPM-Kymmene price target raised to EUR 36.80 from EUR 35.50 at Credit Suisse
Downgrade	Landos Biopharma downgraded to Market Perform from Outperform at Raymond James » 05:51 08/12/22 08/12 05:51 08/12/22 05:51 LABP Landos Biopharma $1.09 / -0.13 (-10.66%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LABP Landos Biopharma $1.09 / -0.13 (-10.66%) 08/11/22 Landos Biopharma expects cash to fund operations for at least next 12 months 08/03/22 Landos Biopharma announces top-line results from NX-13 Phase 1b trial 06/21/22 Landos Biopharma appoints Gregory Oakes as president, CEO 03/10/22 Landos Biopharma appoints Roger Adsett to board of directors LABP Landos Biopharma $1.09 / -0.13 (-10.66%) 04/12/22 Jefferies Jefferies downgrades Landos Biopharma, slashes target on 'uncertain' pipeline 04/12/22 Jefferies Landos Biopharma downgraded to Hold from Buy at Jefferies 03/25/22 Raymond James Landos Biopharma price target lowered to $9 from $24 at Raymond James 11/18/21 Craig-Hallum Landos Biopharma price target lowered to $29.50 from $45 at Craig-Hallum LABP Landos Biopharma $1.09 / -0.13 (-10.66%) 08/11/22 Landos Biopharma reports Q2 EPS (28c), consensus (33c) 03/24/22 Landos Biopharma reports FY21 EPS ($1.02), consensus (88c)
Initiation	Lexicon initiated with an Overweight at Piper Sandler » 05:50 08/12/22 08/12 05:50 08/12/22 05:50 LXRX Lexicon $2.75 / -0.03 (-1.08%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LXRX Lexicon $2.75 / -0.03 (-1.08%) 08/02/22 Lexicon reports Q2 EPS (16c), consensus (16c) 07/27/22 Lexicon announces FDA acceptance of NDA for sotagliflozin 06/29/22 Lexicon Pharmaceuticals trading resumes 06/29/22 Lexicon proof-of-concept study of LX9211 achieves primary endpoint LXRX Lexicon $2.75 / -0.03 (-1.08%) 07/01/22 Citi Citi disagrees with Lexicon selloff yesterday, ups target to $20 03/01/22 Citi Lexicon selloff on filing delay a buying opportunity, says Citi 08/30/21 Citi Lexicon price target raised to $20 from $13 at Citi LXRX Lexicon $2.75 / -0.03 (-1.08%) 05/05/22 Lexicon reports Q1 EPS (16c), consensus (16c) 02/28/22 Lexicon reports Q4 EPS (17c), consensus (18c)
Downgrade	Olo downgraded to Neutral from Overweight at Piper Sandler » 05:47 08/12/22 08/12 05:47 08/12/22 05:47 OLO Olo $13.00 / -0.235 (-1.78%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly OLO Olo $13.00 / -0.235 (-1.78%) 05/10/22 Olo appoints Diego Panama as chief revenue officer 04/14/22 Olo, SOCi partner for SOCi integration with Olo API 03/04/22 Olo announces integration with Radar 02/23/22 Olo launches Olo Pay OLO Olo $13.00 / -0.235 (-1.78%) 05:26 Today Stifel Olo downgraded to Hold from Buy at Stifel 07/18/22 Piper Sandler Olo price target lowered to $13 from $14 at Piper Sandler 06/17/22 JPMorgan Olo price target lowered to $21 from $26 at JPMorgan 02/24/22 Truist Olo price target lowered to $25 from $45 at Truist OLO Olo $13.00 / -0.235 (-1.78%) 08/11/22 Olo cuts FY22 revenue view to $183M-$184M, consensus $195.6M 08/11/22 Olo sees Q3 revenue $46.5M-$47.0M, consensus $51.1M 08/11/22 Olo reports Q2 EPS 1c, consensus 0c 05/10/22 Olo sees Q2 revenue $45.5M-$46M, consensus $45.48M OLO Olo $13.00 / -0.235 (-1.78%) 08/11/22 Fly Intel: After-Hours Movers
Periodicals	Samsung heir Jay Y. Lee to receive presidential pardon, Bloomberg reports » 05:46 08/12/22 08/12 05:46 08/12/22 05:46 SSNLF Samsung $57.75 / + (+0.00%) Samsung heir Jay Y. Lee… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly SSNLF Samsung $57.75 / + (+0.00%) 07/28/22 Samsung Display segment Q2 earnings 'solid despite weak seasonality' 07/27/22 Qualcomm, Samsung extend, expand strategic partnership 06/30/22 Samsung begins chip production using 3nm process technology 06/09/22 Microsoft, Samsung partner to bring Xbox Cloud Gaming to Samsung Smart TVs SSNLF Samsung $57.75 / + (+0.00%) 08/11/22 Loop Capital Loop Capital has 'stronger conviction' in Enovix after 'customer milestones' 06/22/22 Loop Capital Samsung initiated with a Buy at Loop Capital 06/13/22 KeyBanc Qualcomm price target raised to $220 from $200 at KeyBanc 06/13/22 UBS Micron price target lowered to $115 from $120 at UBS SSNLF Samsung $57.75 / + (+0.00%) 07/28/22 Samsung reports Q2 EPS KRW 1,613 vs. KRW 1,391 last year 07/06/22 Samsung sees Q2 operating profit KRW14.0T vs. KRW14.6T consensus 04/28/22 Samsung reports Q1 EPS KRW 1,638 vs. KRW 1,044 last year 04/06/22 Samsung sees Q1 operating profit KRW14.1T vs. KRW13.4T consensus SSNLF Samsung $57.75 / + (+0.00%) 08/09/22 Samsung plans $3.3B investment in Vietnam, South China Morning Post reports 08/03/22 Samsung rethinking China exposure amid Chips and Science Act, FT reports 07/21/22 Samsung considering building 11 chipmaking facility, American-Statesman reports 07/18/22 Samsung may hold latest foldable launch event on August 10, Verge says SSNLF Samsung $57.75 / + (+0.00%) 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed This Week in Video Games 06/14/22 What You Missed This Week in Video Games
Downgrade	Six Flags downgraded to Sector Weight at KeyBanc after 'indefensible' Q2 » 05:44 08/12/22 08/12 05:44 08/12/22 05:44 SIX Six Flags $21.12 / -4.685 (-18.16%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SIX Six Flags $21.12 / -4.685 (-18.16%) 08/11/22 Six Flags falls -22.5% 08/11/22 Six Flags falls -21.5% 08/11/22 Six Flags falls -18.1% 08/11/22 Six Flags reports Q2 attendance 6.7M vs. 8.5M a year ago, down 22% SIX Six Flags $21.12 / -4.685 (-18.16%) 08/11/22 KeyBanc Six Flags downgraded to Sector Weight from Overweight at KeyBanc 07/08/22 Citi Six Flags downgraded to Neutral from Buy at Citi 06/24/22 Stifel Six Flags price target lowered to $35 from $52 at Stifel 06/21/22 B. Riley Six Flags downgraded to Neutral from Buy at B. Riley SIX Six Flags $21.12 / -4.685 (-18.16%) 08/11/22 Six Flags reports Q2 EPS 53c, consensus $1.02 08/10/22 Notable companies reporting before tomorrow's open 08/10/22 Notable companies reporting before tomorrow's open 05/12/22 Six Flags reports Q1 EPS (76c), consensus ($1.04) SIX Six Flags $21.12 / -4.685 (-18.16%) 08/11/22 What You Missed On Wall Street On Thursday 08/11/22 What You Missed On Wall Street This Morning 08/11/22 Fly Intel: Pre-market Movers 07/21/22 Fly Intel: After-Hours Movers

Downgrade	Cowen cuts CS Disco to Market Perform as momentum hits 'big snag' » 05:40 08/12/22 08/12 05:40 08/12/22 05:40 LAW CS Disco $28.96 / +0.39 (+1.37%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly LAW CS Disco $28.96 / +0.39 (+1.37%) 06/06/22 DISCO appoints Tom Furr as CMO 06/01/22 CS Disco falls -10.8% 04/28/22 DISCO appoints Jignasha Amin Grooms as CHRO LAW CS Disco $28.96 / +0.39 (+1.37%) 05:35 Today Cowen CS Disco downgraded to Market Perform from Outperform at Cowen 05:22 Today Jefferies CS Disco downgraded to Hold from Buy at Jefferies 05/23/22 Jefferies CS Disco price target lowered to $35 from $40 at Jefferies 05/13/22 Needham CS Disco price target lowered to $35 from $50 at Needham LAW CS Disco $28.96 / +0.39 (+1.37%) 08/11/22 CS Disco cuts FY22 revenue view to $132M-$136M from $149M-$153M 08/11/22 CS Disco sees Q3 revenue $32M-$34M, consensus $38.29M 08/11/22 CS Disco reports Q2 adjusted (23c), consensus (27c) 05/12/22 CS Disco sees Q2 revenue $32M-$34M, consensus $34.02M 15 Sep LAW CS Disco $28.96 / +0.39 (+1.37%) 08/11/22 Fly Intel: After-Hours Movers 05/12/22 Fly Intel: After-Hours Movers
Downgrade	RealReal downgraded to Market Perform from Outperform at Cowen » 05:38 08/12/22 08/12 05:38 08/12/22 05:38 REAL RealReal $3.16 / +0.065 (+2.10%) Cowen analyst Oliver Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options REAL RealReal $3.16 / +0.065 (+2.10%) 07/27/22 RealReal enters partnership with Beckett Collectibles 06/07/22 RealReal announces Founder Julie Wainwright to stepdown from CEO role 04/29/22 RealReal announces expansion of Sustainability Calculator 03/22/22 RealReal provides long-range financial targets for FY25 REAL RealReal $3.16 / +0.065 (+2.10%) 08/10/22 Wells Fargo RealReal price target lowered to $8 from $15 at Wells Fargo 08/10/22 Needham RealReal price target lowered to $6 from $10 at Needham 08/10/22 Wedbush RealReal price target lowered to $5 from $10 at Wedbush 08/10/22 BofA RealReal double downgraded to Underperform at BofA REAL RealReal $3.16 / +0.065 (+2.10%) 08/09/22 RealReal sees Q3 revenue $145M-$155M, consensus $164.08M 08/09/22 RealReal sees FY22 revenue $615M-$635M, consensus $652.44M 08/09/22 RealReal reports Q2 adjusted EPS (40c), consensus (43c) 08/09/22 Notable companies reporting after market close REAL RealReal $3.16 / +0.065 (+2.10%) 08/10/22 What You Missed On Wall Street On Wednesday 08/10/22 What You Missed On Wall Street This Morning 08/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/09/22 Fly Intel: After-Hours Movers REAL RealReal $3.16 / +0.065 (+2.10%) 08/09/22 RealReal options imply 16.1% move in share price post-earnings 02/23/22 RealReal options imply 16.4% move in share price post-earnings
Downgrade	e.l.f. Beauty downgraded to Market Perform from Outperform at Cowen » 05:38 08/12/22 08/12 05:38 08/12/22 05:38 ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) Cowen analyst Oliver Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 07/05/22 Chairman of e.l.f. Beauty Tarang Amin sells $1.3M in company shares 06/07/22 e.l.f. Beauty CEO: We continue to take market share ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 08/04/22 Truist e.l.f. Beauty price target raised to $40 from $35 at Truist 07/21/22 JPMorgan e.l.f. Beauty price target raised to $35 from $30 at JPMorgan 05/26/22 Raymond James e.l.f. Beauty price target lowered to $27 from $33 at Raymond James 05/26/22 Morgan Stanley e.l.f. Beauty sounded 'very bullish' on earnings call, says Morgan Stanley ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 08/03/22 e.l.f. Beauty raises FY23 EPSE view to 84c-87c from 78c-81c 08/03/22 e.l.f. Beauty reports Q1 EPS 39c, consensus 23c 05/25/22 e.l.f. Beauty sees FY23 adjusted EPS 78c-81c, consensus 84c 05/25/22 e.l.f. Beauty reports Q4 adjusted EPS 13c, consensus 6c ELF e.l.f. Beauty $36.44 / -0.02 (-0.05%) 07/11/22 Fly Insider: Karuna Therapeutics, HP among weeks notable insider trades 05/25/22 Fly Intel: After-Hours Movers 04/06/22 What You Missed On Wall Street On Wednesday 04/06/22 What You Missed On Wall Street This Morning 11/02/22 e.l.f. Beauty - ELF 08/25/22 E.L.F. BEAUTY 09/13/22 e.l.f. Beauty 09/14/22 e.l.f. Beauty
Upgrade	Ciena upgraded to Overweight at Morgan Stanley as supply chain improves » 05:36 08/12/22 08/12 05:36 08/12/22 05:36 CIEN Ciena $52.90 / -1.08 (-2.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CIEN Ciena $52.90 / -1.08 (-2.00%) 06/02/22 Ciena falls -8.3% 06/02/22 Ciena sees Q3 OpEx $305M-$310M 06/02/22 Ciena CEO: Long-term secular drivers creating 'incredible' demand environment 06/02/22 Ciena CEO: Supply chain conditions worsened throughout quarter, says CEO CIEN Ciena $52.90 / -1.08 (-2.00%) 05:30 Today Morgan Stanley Ciena upgraded to Overweight from Equal Weight at Morgan Stanley 08/04/22 MKM Partners Ciena assumed with a Buy at MKM Partners 07/14/22 JPMorgan Ciena price target lowered to $62 from $72 at JPMorgan 07/14/22 JPMorgan JPMorgan adds Qualcomm to Analyst Focus List, removes Ciena CIEN Ciena $52.90 / -1.08 (-2.00%) 06/02/22 Ciena sees FY revenue growth in mid single digits, consensus $4.06B 06/02/22 Ciena sees Q3 revenue $870M-$930M, consensus $1.08B 06/02/22 Ciena reports Q2 adjusted EPS 50c, consensus 54c 06/01/22 Notable companies reporting before tomorrow's open CIEN Ciena $52.90 / -1.08 (-2.00%) 06/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/02/22 What You Missed On Wall Street On Thursday 06/02/22 What You Missed On Wall Street This Morning 06/02/22 Fly Intel: Pre-market Movers
Downgrade	Centessa double downgraded to Underweight from Overweight at Morgan Stanley » 05:36 08/12/22 08/12 05:36 08/12/22 05:36 CNTA Centessa $4.27 / -0.43 (-9.15%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options CNTA Centessa $4.27 / -0.43 (-9.15%) 08/10/22 Centessa to discontinue development of ZF874 07/25/22 Centessa appoints Rotmas as SVP, Regulatory Affairs 07/18/22 Evelo Biosciences names Marella Thorell as CFO, effective September 1 07/01/22 Centessa appoints Mathias Hukkelhoven to board of directors CNTA Centessa $4.27 / -0.43 (-9.15%) 05:29 Today Morgan Stanley Centessa downgraded to Underweight from Overweight at Morgan Stanley 08/11/22 BMO Capital Centessa price target lowered to $11 from $19 at BMO Capital 06/16/22 BMO Capital Centessa initiated with an Outperform at BMO Capital 06/03/22 Jefferies Centessa downgraded to Hold from Buy at Jefferies CNTA Centessa $4.27 / -0.43 (-9.15%) 08/10/22 Centessa reports Q2 EPS (69c) vs. (65c) a year ago 05/16/22 Centessa reports Q1 EPS (60c), consensus (70c) 03/30/22 Centessa reports Q4 EPS (68c), consensus (60c) CNTA Centessa $4.27 / -0.43 (-9.15%) 07/07/22 Eighteen new option listings and one option delisting on July 7th
Downgrade	CS Disco downgraded to Market Perform from Outperform at Cowen » 05:35 08/12/22 08/12 05:35 08/12/22 05:35 LAW CS Disco $28.96 / +0.39 (+1.37%) Cowen analyst J. Derrick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly LAW CS Disco $28.96 / +0.39 (+1.37%) 06/06/22 DISCO appoints Tom Furr as CMO 06/01/22 CS Disco falls -10.8% 04/28/22 DISCO appoints Jignasha Amin Grooms as CHRO LAW CS Disco $28.96 / +0.39 (+1.37%) 05:22 Today Jefferies CS Disco downgraded to Hold from Buy at Jefferies 05/23/22 Jefferies CS Disco price target lowered to $35 from $40 at Jefferies 05/13/22 Needham CS Disco price target lowered to $35 from $50 at Needham 05/13/22 Cowen CS Disco price target lowered to $35 from $45 at Cowen LAW CS Disco $28.96 / +0.39 (+1.37%) 08/11/22 CS Disco cuts FY22 revenue view to $132M-$136M from $149M-$153M 08/11/22 CS Disco sees Q3 revenue $32M-$34M, consensus $38.29M 08/11/22 CS Disco reports Q2 adjusted (23c), consensus (27c) 05/12/22 CS Disco sees Q2 revenue $32M-$34M, consensus $34.02M 15 Sep LAW CS Disco $28.96 / +0.39 (+1.37%) 08/11/22 Fly Intel: After-Hours Movers 05/12/22 Fly Intel: After-Hours Movers
General news	Energy Action: » 05:35 08/12/22 08/12 05:35 08/12/22 05:35 $ECON Economic Data / + Energy Action: Oil prices… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Upgrade	Sanofi upgraded to Hold from Sell at Deutsche Bank » 05:33 08/12/22 08/12 05:33 08/12/22 05:33 SNY Sanofi $43.46 / -1.74 (-3.85%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SNY Sanofi $43.46 / -1.74 (-3.85%) 08/11/22 Sanofi says 'confident in its legal defenses' related to U.S. Zantac litigation 08/04/22 Sanofi announces strategic collaboration with Innovent Biologics 07/21/22 Innate Pharma announces Sanofi decision to progress IPH6401/SAR'514 07/18/22 Editas Medicine appoints Mei as SVP, CMO SNY Sanofi $43.46 / -1.74 (-3.85%) 08/11/22 JPMorgan Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan 08/11/22 Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank 08/09/22 UBS Sanofi downgraded to Neutral from Buy at UBS 08/05/22 Stifel Sanofi price target raised to EUR 119 from EUR 115 at Stifel SNY Sanofi $43.46 / -1.74 (-3.85%) 07/28/22 Sanofi sees 2022 business EPS growing 15% at CER 07/28/22 Sanofi reports Q2 business EPS EUR 1.73, up 16.7% at CER 04/28/22 Sanofi still expects 2022 business EPS to grow low double-digit at CER 04/28/22 Sanofi reports Q1 business EPS EUR 1.94, up 16.1% at CER SNY Sanofi $43.46 / -1.74 (-3.85%) 08/11/22 GSK, Sanofi weakness related to Zantac litigation worries, Bloomberg reports SNY Sanofi $43.46 / -1.74 (-3.85%) 08/11/22 What You Missed On Wall Street On Thursday 08/11/22 Renewed Zantac litigation concerns sinking these big-cap drugmakers 08/11/22 What You Missed On Wall Street This Morning 06/24/22 What You Missed On Wall Street On Friday 09/10/22 ESMO Congress 2022
Upgrade	Ciena upgraded to Overweight from Equal Weight at Morgan Stanley » 05:30 08/12/22 08/12 05:30 08/12/22 05:30 CIEN Ciena $52.90 / -1.08 (-2.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CIEN Ciena $52.90 / -1.08 (-2.00%) 06/02/22 Ciena falls -8.3% 06/02/22 Ciena sees Q3 OpEx $305M-$310M 06/02/22 Ciena CEO: Long-term secular drivers creating 'incredible' demand environment 06/02/22 Ciena CEO: Supply chain conditions worsened throughout quarter, says CEO CIEN Ciena $52.90 / -1.08 (-2.00%) 08/04/22 MKM Partners Ciena assumed with a Buy at MKM Partners 07/14/22 JPMorgan Ciena price target lowered to $62 from $72 at JPMorgan 07/14/22 JPMorgan JPMorgan adds Qualcomm to Analyst Focus List, removes Ciena 07/12/22 Rosenblatt Juniper initiated with a Neutral at Rosenblatt CIEN Ciena $52.90 / -1.08 (-2.00%) 06/02/22 Ciena sees FY revenue growth in mid single digits, consensus $4.06B 06/02/22 Ciena sees Q3 revenue $870M-$930M, consensus $1.08B 06/02/22 Ciena reports Q2 adjusted EPS 50c, consensus 54c 06/01/22 Notable companies reporting before tomorrow's open CIEN Ciena $52.90 / -1.08 (-2.00%) 06/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/02/22 What You Missed On Wall Street On Thursday 06/02/22 What You Missed On Wall Street This Morning 06/02/22 Fly Intel: Pre-market Movers
Downgrade	Centessa downgraded to Underweight from Overweight at Morgan Stanley » 05:29 08/12/22 08/12 05:29 08/12/22 05:29 CNTA Centessa $4.27 / -0.43 (-9.15%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options CNTA Centessa $4.27 / -0.43 (-9.15%) 08/10/22 Centessa to discontinue development of ZF874 07/25/22 Centessa appoints Rotmas as SVP, Regulatory Affairs 07/18/22 Evelo Biosciences names Marella Thorell as CFO, effective September 1 07/01/22 Centessa appoints Mathias Hukkelhoven to board of directors CNTA Centessa $4.27 / -0.43 (-9.15%) 08/11/22 BMO Capital Centessa price target lowered to $11 from $19 at BMO Capital 06/16/22 BMO Capital Centessa initiated with an Outperform at BMO Capital 06/03/22 Jefferies Centessa downgraded to Hold from Buy at Jefferies 02/11/22 Goldman Sachs Centessa assumed with a Neutral at Goldman Sachs CNTA Centessa $4.27 / -0.43 (-9.15%) 08/10/22 Centessa reports Q2 EPS (69c) vs. (65c) a year ago 05/16/22 Centessa reports Q1 EPS (60c), consensus (70c) 03/30/22 Centessa reports Q4 EPS (68c), consensus (60c) CNTA Centessa $4.27 / -0.43 (-9.15%) 07/07/22 Eighteen new option listings and one option delisting on July 7th

Downgrade	II-VI downgraded to Equal Weight from Overweight at Morgan Stanley » 05:28 08/12/22 08/12 05:28 08/12/22 05:28 IIVI II-VI $52.52 / +0.38 (+0.73%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events IIVI II-VI $52.52 / +0.38 (+0.73%) 07/18/22 II-VI, Artilux demonstrate a 3D camera for the metaverse 07/11/22 BCPE Watson reports 12.3% stake in II-VI, plans active role 07/05/22 Omnicell to replace Coherent in S&P 400 at open on 7/5 07/01/22 II-VI completes acquisition of Coherent IIVI II-VI $52.52 / +0.38 (+0.73%) 07/25/22 Barclays II-VI price target lowered to $47 from $65 at Barclays 07/01/22 Craig-Hallum II-VI price target lowered to $80 from $85 at Craig-Hallum 05/17/22 Piper Sandler Piper moves to 'more positive stance' on semiconductor stocks 05/10/22 Raymond James II-VI price target raised to $82 from $79 at Raymond James IIVI II-VI $52.52 / +0.38 (+0.73%) 05/10/22 II-VI sees Q4 adjusted EPS 85c-$1.00, consensus 92c 05/10/22 II-VI reports Q3 adjusted EPS 95c, consensus 85c 05/09/22 Notable companies reporting before tomorrow's open 05/09/22 Notable companies reporting before tomorrow's open IIVI II-VI $52.52 / +0.38 (+0.73%) 06/23/22 China to conditionally clear II-VI deal to buy Coherent, Dealreporter says 05/18/22 II-VI, Coherent see uncertainty added to SAMR deal reviews, Capitol Forum says IIVI II-VI $52.52 / +0.38 (+0.73%) 06/28/22 What You Missed On Wall Street On Tuesday 06/28/22 What You Missed On Wall Street This Morning 05/18/22 What You Missed On Wall Street On Wednesday 05/18/22 What You Missed On Wall Street This Morning 08/24/22 II-VI - IIVI
Downgrade	Olo downgraded to Hold from Buy at Stifel » 05:26 08/12/22 08/12 05:26 08/12/22 05:26 OLO Olo $13.00 / -0.235 (-1.78%) Stifel analyst Brad… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly OLO Olo $13.00 / -0.235 (-1.78%) 05/10/22 Olo appoints Diego Panama as chief revenue officer 04/14/22 Olo, SOCi partner for SOCi integration with Olo API 03/04/22 Olo announces integration with Radar 02/23/22 Olo launches Olo Pay OLO Olo $13.00 / -0.235 (-1.78%) 07/18/22 Piper Sandler Olo price target lowered to $13 from $14 at Piper Sandler 06/17/22 JPMorgan Olo price target lowered to $21 from $26 at JPMorgan 02/24/22 Truist Olo price target lowered to $25 from $45 at Truist 02/24/22 Piper Sandler Olo price target lowered to $20 from $33 at Piper Sandler OLO Olo $13.00 / -0.235 (-1.78%) 08/11/22 Olo cuts FY22 revenue view to $183M-$184M, consensus $195.6M 08/11/22 Olo sees Q3 revenue $46.5M-$47.0M, consensus $51.1M 08/11/22 Olo reports Q2 EPS 1c, consensus 0c 05/10/22 Olo sees Q2 revenue $45.5M-$46M, consensus $45.48M OLO Olo $13.00 / -0.235 (-1.78%) 08/11/22 Fly Intel: After-Hours Movers
Downgrade	CS Disco downgraded to Hold from Buy at Jefferies » 05:22 08/12/22 08/12 05:22 08/12/22 05:22 LAW CS Disco $28.96 / +0.39 (+1.37%) Jefferies analyst Brent… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly LAW CS Disco $28.96 / +0.39 (+1.37%) 06/06/22 DISCO appoints Tom Furr as CMO 06/01/22 CS Disco falls -10.8% 04/28/22 DISCO appoints Jignasha Amin Grooms as CHRO LAW CS Disco $28.96 / +0.39 (+1.37%) 05/23/22 Jefferies CS Disco price target lowered to $35 from $40 at Jefferies 05/13/22 Needham CS Disco price target lowered to $35 from $50 at Needham 05/13/22 Cowen CS Disco price target lowered to $35 from $45 at Cowen 05/13/22 Canaccord CS Disco price target lowered to $35 from $45 at Canaccord LAW CS Disco $28.96 / +0.39 (+1.37%) 08/11/22 CS Disco cuts FY22 revenue view to $132M-$136M from $149M-$153M 08/11/22 CS Disco sees Q3 revenue $32M-$34M, consensus $38.29M 08/11/22 CS Disco reports Q2 adjusted (23c), consensus (27c) 05/12/22 CS Disco sees Q2 revenue $32M-$34M, consensus $34.02M 15 Sep LAW CS Disco $28.96 / +0.39 (+1.37%) 08/11/22 Fly Intel: After-Hours Movers 05/12/22 Fly Intel: After-Hours Movers
Downgrade	Eutelsat downgraded to Underweight from Neutral at JPMorgan » 05:19 08/12/22 08/12 05:19 08/12/22 05:19 ETCMY Eutelsat $2.27 / + (+0.00%) JPMorgan analyst Akhil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ETCMY Eutelsat $2.27 / + (+0.00%) 07/27/22 Deutsche Bank Eutelsat price target lowered to EUR 10 from EUR 13 at Deutsche Bank 07/27/22 Deutsche Bank Eutelsat downgraded to Hold from Buy at Deutsche Bank 07/26/22 Kepler Cheuvreux Eutelsat downgraded to Hold from Buy at Kepler Cheuvreux 07/13/22 Barclays Eutelsat price target raised to EUR 12.65 from EUR 12 at Barclays
Downgrade	Television Francaise 1 downgraded to Underweight from Overweight at Barclays » 05:16 08/12/22 08/12 05:16 08/12/22 05:16 TVFCF Television Francaise 1 $8.87 / + (+0.00%) Barclays analyst Julien… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TVFCF Television Francaise 1 $8.87 / + (+0.00%) 07/20/22 UBS Television Francaise 1 price target lowered to EUR 7.20 from EUR 9.80 at UBS 02/15/22 Barclays Television Francaise 1 price target raised to EUR 13 from EUR 12.25 at Barclays 12/10/21 Barclays Television Francaise price target lowered to EUR 10.50 from EUR 11 at Barclays 11/01/21 Barclays Television Francaise 1 price target raised to EUR 11 from EUR 10.80 at Barclays

Events

Earnings calls, analyst events, roadshows and more

EVK
Today at 08:00

Ever-Glory - EVK Conference Calls
CMMB
Today at 08:00

Chemomab Therapeutics - CMMB Conference Calls
HUMA
Today at 08:00

Humacyte - HUMA Conference Calls
CAAS
Today at 08:00

China Automotive - CAAS Conference Calls
CASI
Today at 08:00

Casi Pharmaceuticals - CASI Conference Calls
GTEC
Today at 08:00

Greenland Technologies - GTEC Conference Calls
VERO
Today at 08:00

Venus Concept - VERO Conference Calls
Today at 08:30

Export Prices M/M: July 2022 Government Event
Today at 08:30

Export Prices Y/Y: July 2022 Government Event
Today at 08:30

Import Prices M/M: July 2022 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo Priced at: $42.85 1.17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity Priced at: $5.00 3M Shares REBN X REBN Reborn Coffee IPO Managers: EF Hutton Priced at: $5.00 1.44M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler Priced at: $23.75 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	No deals
Thurs	CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams $41.42 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $11.11 CERT X CERT Certara Spot Secondary Managers: Morgan Stanley $17.75-18.50 7M Shares INSP X INSP Inspire Medical Spot Secondary Managers: Goldman Sachs $215.00-222.46 1M Shares
Fri	No deals

View All Syndicate Announcements »

American Rebel to acquire Champion Safe Company in $9.9M transaction

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access